For preconception and pregnant women who require increased folate concentrations
Zervalx™ Bottle and Tablet
Zervalx™ NDC#: 0525-101-90
| AmerisourceBergen (BBC#) | 271-515 |
| AmerisourceBergen (AAS#) | 5054192 |
| Cardinal (CIN#) | 4073896 |
| Cardinal (DP#) | 407389 |
| H.D. Smith | 2147049 |
| LA W'sale | |
| McKesson (Economost #) | 1317429 |
| McQuery Bros | 297-461 |
| Morris & Dickson | 847178 |
| N.C. Mutual | 659-920 |
| Smith Drug | 39528 |
Zervalx™ is an orally administered prescription medical food for the dietary management of the following patient conditions:
preconception hyperhomocysteinemia; and/or, intermediate- to higher- risk pregnancies which require an increased dietary folate intake; and/or, hemolytic, megaloblastic, and/or sickle cell anemia complicated by folate deficiency; and/or experiencing methotrexate induced plasma hyperhomocysteinemia. Zervalx™ should always be used under the supervision of a physician.
© 2008, Pamlab, LLC, Covington, LA. (985) 893-4097 Zervalx is a registered trademark of Pamlab, L.L.C. All rights reserved.